Introduction
Traumatic injury, congenital defects, or tumor ablations cause skeletal muscle defects and as a promising interdisciplinary specialty skeletal muscle tissue engineering aims at the reconstruction of this loss. There are limitations for autologous grafting because of the difficulty in procuring donor tissue. Transfer of an adjacent muscle tissue in a pediculated form or a distant one as a free flap is a method often applied in treatment of muscular defects and losses. The goal here is sometimes just to cover the defect, but this approach may also be used to restore the functionality of a contractile muscle. However, long and difficult surgical procedures are required and sometimes donor site morbidity brings surgical procedure limitations. Since the muscles used for coverage sometimes do not have neural transmission, secondary surgeries are carried out to provide neurotization and innervation. Generating new muscle tissue from autologous precursor cells (stem cells) attempts to manage this problem via skeletal muscle tissue engineering (Guettier-Sigrist, 1998 ).
Skeletal muscle consists of basically three major cell types: myofibers, neurons, and endothelial cells, which are actively involved in the muscle contraction phenomenon. Myofibers are large single cells that are formed by fusion of many cells during development. Bundling of these muscle fibers results in muscle formation (Sjøgaard et al., 2014) . Skeletal muscle cells are innervated by motor neurons. Each neuron can control a small number of myofibers and fires a contraction. There is a need for neuronal stimulation during myogenesis (Pette et al., 2002) . With the help of tissue engineering principles, differentiated skeletal muscle tissue can be restored by utilizing multiple stem or progenitor cells from different sources.
Due to terminal differentiation of mature muscle fibers, which are vascularized and multinucleated, selfregeneration is not possible. Satellite cells or myoblasts, first described by Mauro in 1961 , are the cells that give the muscle tissue the ability to regenerate itself. Muscle injury causes myoblast activation by external stimuli. They reenter the mitotic cell cycle and form new myofibers or fuse with damaged myofibers (Laumonier and Menetrey, 2016) . Some of the cells reenter the G0 state and therefore are capable of maintaining the regenerative potential of injured muscle tissue (Dhawan and Rondo, 2005; Sinanan et al., 2006; Dumont et al., 2015; Snijders et al., 2015) .
The most preferred source of cells for skeletal muscle tissue engineering applications is either a myoblast cell line (Caridade et al., 2015) or the primary satellite cells that can easily be obtained by muscle biopsies and be cultured in vitro (Powell et al., 1999) . As pioneers in this field, several research groups have focused on engineering skeletal muscle tissue that harbored only the myoblasts in their structure (Choi et al., 2008; Moon et al., 2008; Eberli et al., 2009; Hosseini et al., 2012) . The major goal of these studies was to obtain the contracting myotubes in an anisotropic arrangement to mimic the native skeletal muscle physiology. These were closely followed by other reports that introduced methods for vascularization of engineered constructs (De Coppi et al., 2005; Levenberg et al., 2005; Delo et al., 2008; Klumpp et al., 2012; Shandalov et al., 2014 Shandalov et al., , 2015 . Most approaches were dependent on the host for generation of a blood vessel system that could provide enough oxygen and nutrients for survival (De Coppi et al., 2005; Delo et al., 2008; Klumpp et al., 2012; Juhas et al., 2014) . However, in expanded tissues with a high oxygen demand like skeletal muscle, vascularization is a fundamental concern and its prior in vitro establishment would better help in vivo survival and integration of the 3D implant. Introduction of a capillary network to the in vitro tissue-engineered muscle was a good strategy (Levenberg et al., 2005; Shandalov et al., 2014 Shandalov et al., , 2015 Gholobova et al., 2015) , and the in vivo integration of such a construct was found to be more successful (Levenberg et al., 2005; Shandalov et al., 2014) . As the other invaluable component of muscle tissue, in vitro establishment of innervation by the motor neurons would better mimic the native tissue and provide an opportunity to test the effect of drugs targeting the neuromuscular junctions (Uzel et al., 2016) . It was shown in a study by Guo et al. (2011) that an in vitro functional human neuromuscular junction can be established by coculture of motoneurons derived from human fetal spinal cord stem cells and myotubes derived from human skeletal muscle stem cells in a defined serumfree system. Larkin et al. (2007) were successful in obtaining a functional neuromuscular junction in vitro when they used a model where 3D skeletal muscle constructs were cocultured with fetal nerve explants. On the other hand, both innervated and vascularized human muscle tissue construct is expected to have a reduced time of functional integration in the body and eliminate the species-related variability associated with animal-based systems when used in drug discovery and toxicology studies.
This study reports a human-based improved in vitro skeletal muscle model developed by coculture of human neuron-like cells and myotubes obtained by differentiating human skeletal muscle-derived stem cells and endothelial cells from human umbilical vein. Neuron-like cells were seeded on myotubes that possessed a capillary network and these were cultured all together for 24 h. Neuronmyotube interaction and capillary network maintenance was revealed by confocal microscopy.
Materials and methods

Human skeletal muscle stem cell isolation
Human skeletal muscle stem cells (hSkMSCs) were isolated with the enzymatic digestion of muscle obtained from hamstring grafts for anterior cruciate ligament surgery under the guidelines of the Yeditepe University Hospital Human Ethics Committee.
The nonpathological human skeletal muscle tissue was taken into Hank's Balanced Salt Solution (HBSS; GIBCO, USA) with 5% Pen/Strep (Biochrom AC, Germany) and divided into small pieces with the help of a scalpel. An enzyme cocktail containing 0.1% collagenase I (SigmaAldrich, USA) and 1.38 mg/mL dispase (GIBCO) was prepared in HBSS and the muscle pieces were incubated in this solution in a shaking water bath for 2 h at 37 °C. The final slurry was filtered through a filter with 100 µm pore size and the filtrate was centrifuged at 1500 rpm for 5 min. The cells in the pellet were resuspended in media for washing and centrifuged again under the same conditions. The pellet was resuspended in DMEM/F12 (1:1) medium supplemented with 20% fetal bovine serum (FBS), 20 µg/L human recombinant epidermal growth factor (EGF) (Sigma-Aldrich), and 10 µg/L basic fibroblast growth factor (bFGF) (Sigma-Aldrich) and precultured on gelatin-coated flasks, called preplates, for 3 h to reduce the number of fibroblasts. The unattached cells were transferred together with the medium to a new uncoated T25 flask and cultured at 37 °C in a 5% CO 2 incubator. The media in the flasks were refreshed every third day, and at a 70% confluency state, the cells were trypsinized with 0.25% trypsin-EDTA for 5 min at 37 °C and subcultured. Phase-contrast microscope images were taken at day 4 of the primary culture. 2.2. Human skeletal muscle stem cell characterization by flow cytometry hSkMSCs were differentiated into two types of cells: skeletal muscle cells and neuron-like cells. In order to characterize the differentiation capacity of hSkMSCs, flow cytometry was carried out. Immunophenotyping of hSkMSCs was performed with antibodies against the following cell surface antigens (BD Pharmingen, USA): CD44 (hyaluronate/lymphocyte homing associated cell adhesion molecule: HCAM), CD34 (hematopoietic progenitor cell antigen), CD45 (protein tyrosine phosphatase, receptor type, C/PTPRC/leukocyte common antigen/cell marker of hematopoietic origin), CD90 (Thy-1/Thy-1.1), and CD105 (endoglin). Cells (1 × 10 4 ) were immunostained for each antibody and analyzed by BD FACSCalibur flow cytometer (BD Biosciences, USA). Samples were normalized to an isotype control.
Myotube formation
The hSkMSCs were counted with a hemocytometer and the cell concentration was calculated. The cells were plated on a tissue culture dish approximately at 3 × 10 3 cells/cm 2 using DMEM/F12 medium supplemented with 20% FBS, 20 µg/L EGF, and 10 µg/L bFGF. Following 24 h of incubation, the FBS percentage was lowered to 10%. At the end of 7 and 14 days of incubation, the multinucleated myotubes were observed under a light microscope. Immunocytochemical staining was carried out using the streptavidin-peroxidase method (UltraVision Plus Large Volume Detection System Anti-Polyvalent, HRP Immunostaining Kit; Thermo Scientific, UK) to reveal the desmin positive myotubes obtained after 7 days of incubation. Briefly, cultured cells were fixed in ice-cold methanol with 0.3% hydrogen peroxide for 15 min and allowed to dry. After washing with phosphate-buffered saline (PBS), the cells were incubated with Ultra V Block for 5 min at room temperature and then with the primary antibody for desmin (sc-14026; Santa Cruz Biotechnology, USA) overnight at 4 °C. The following day, biotinylated secondary antibody was added and cells were incubated for 15 min at room temperature. Streptavidin peroxidase treatment was then carried out for 15 min at room temperature. The signal was detected with the AEC kit (Zymed Laboratories/Invitrogen, USA). After being counter-stained with hematoxylin (Santa Cruz Biotechnology), cells were examined under a light microscope.
Neuron-like cell differentiation
The hSkMSCs were counted with a hemocytometer and the cells were plated on a tissue culture dish (approximately 1.5 × 10 3 cells/cm 2 ) using DMEM/F12 medium supplemented with 20% FBS, 20 µg/L EGF, and 10 µg/L bFGF. Cell morphology was observed after 24 h of incubation to ensure cell attachment to the surface. The cells were rinsed twice with DPBS and complete neural differentiation medium (AdvanceSTEM Neural Differentiation Medium and AdvanceSTEM Stem Cell Growth Supplement (Thermo) mixed in a 9:1 ratio according to the manufacturer's recommendation) was added. The cells were incubated at 37 °C in a 5% CO 2 incubator. Every 48 h, the neural differentiation medium was refreshed. Neuronal differentiation was observed as neuron-like cells appeared within 24 h and peaked at 72 h of incubation. In order to maintain cells in their differentiated state, additional neural differentiation medium was added every 48 h.
Neuron-like cell characterization by immunostaining
The cells were incubated in an incubator for 3 days in complete neural differentiation media and finally fixed and immunostained for beta-tubulin3 (Santa Cruz, sc-69966), nestin (Santa Cruz, sc-21248), and GFAP (Santa Cruz, sc-6171). Briefly, the cells on the slides were rinsed with PBS and fixed in cold 3.7% formaldehyde for 10 min at RT. After a subsequent wash in PBS, the slides were incubated with 1.5% blocking serum of the species used to raise the secondary antibodies (Santa Cruz Biotechnology) for 20 min at 37 °C to suppress the nonspecific binding of IgGs. After washing three times with PBS for 5 min each, the cells were incubated overnight at 4 °C with the primary antibodies specific for the beta-tubulin3 and GFAP or nestin. After washing 3 times, the slides were incubated with secondary antimouse and antirabbit antibodies, respectively, for 45 min in dark. Finally the samples were counterstained with DAPI (Sigma-Aldrich) for 15 min, washed three times again, mounted, and observed under a confocal microscope (LSM; Zeiss, Germany).
Isolation of HUVECs
Collection of umbilical cords was done after full-term births with informed consent of the mothers, who had a normal delivery or cesarean section. They were aseptically stored at 4 °C in HBSS with 2% Pen/Strep until processing. The cords were washed extensively with PBS to remove the blood clots. Culture medium was flushed through the vein to blow out the coagulated blood. One end of the vein was closed with a clamp and, after air removal, it was filled with 0.1% collagenase I (from Clostridium histolyticum, GIBCO) prepared in HBSS, and the open end was closed with another clamp to retain the enzyme solution in the vein. The umbilical cord was placed into a 50-mL Falcon tube containing warm PBS and incubated in a shaking water bath at 37 °C for 25 min. One end of the vein was cut, the enzyme solution containing the endothelial cells was taken into a 15-mL Falcon tube, and the lumen of the vein was washed with the medium to retrieve all detaching endothelial cells. After centrifugation, the cell pellet was resuspended in endothelial cell growth medium-2 (EGM-2; Lonza) completed with 2% FBS and transferred into a gelatin-coated T25 flask. Human umbilical vein endothelial cells (HUVECs) were cultured in a 5% CO 2 incubator at 37 °C until a 70% confluent monolayer was reached. They were then trypsinized and cryopreserved. The purity of HUVECs was determined by immunostaining with the primary antibody specific to the endothelial cell surface marker CD31 (Invitrogen) according to the procedure mentioned in Section 2.5.
Coculture of hSkMSCs and HUVECs
HUVECs were cocultured with the hSkMSCs to test their potential to form a capillary network, which is particularly important in the development of tissue-engineered skeletal muscle constructs.
In order to optimize the hSkMSC and HUVEC coculture, different media compositions were investigated. Growth medium of hSkMSCs (DMEM/F12 medium supplemented with 20% FBS) was tested at different FBS concentrations either alone or in a 1:1 mixture with the growth medium of HUVECs (EGM-2 medium supplemented with 2% FBS). Six types of media were tested in the coculture: 1) DMEM/F12 medium with 5% FBS, 2) DMEM/F12 medium with 10% FBS, 3) DMEM/ F12 medium with 20% FBS, 4) DMEM/F12 medium with 5% FBS : EGM-2 medium with 2% FBS (1:1), 5) DMEM/ F12 medium with 10% FBS : EGM-2 medium with 2% FBS (1:1), and 6) DMEM/F12 medium with 20% FBS : EGM-2 medium with 2% FBS (1:1) (Table) .
hSkMSCs and HUVECs were mixed in a 1:1 ratio and 7 × 10 3 cells/well were seeded on untreated coverslips in 24-well plates. The cells were incubated in an incubator for 13 days in optimization media, then fixed and immunostained. The same procedure as in Section 2.5 was carried out. This time the primary antibodies were changed to myogenic marker desmin (Santa Cruz) and endothelial marker CD31 (Invitrogen).
In vitro human skeletal muscle model: coculture of myotubes, neuron-like cells, and the capillary network
To obtain the in vitro model of the human skeletal muscle, the coculture of hSkMSCs and HUVECs was carried out for 13 days. First, cells were mixed in a 1:1 ratio and seeded (7 × 10 3 cells/well) on untreated coverslips in a 24-well plate. On day 14, the neuron-like cells obtained by differentiating the hSkMSC in a separate culture were trypsinized and added on top of the cocultured cells with a density of 4 × 10 3 cells per well. The coculture containing three different cell types was continued for 24 h in the neural differentiation medium (AdvanceSTEM Neural Differentiation Medium and AdvanceSTEM Stem Cell Growth Supplement (Thermo) mixed in a 9:1 ratio according to the manufacturer's recommendation) and the cells were fixed and immunostained. The procedure mentioned in Section 2.5 was carried out, but the primary antibodies were changed to myogenic marker desmin, endothelial marker CD31, and neuronal marker betatubulin3.
Results
Human skeletal muscle stem cell characterization
Isolated human skeletal muscle stem cells were examined under a phase-contrast microscope and cell morphology was evaluated. The preplate contained mostly cells of fibroblastic morphology, while the flask generated from cells floating in the medium of the preplate contained mainly myoblasts that formed colonies ( Figures 1A and  1B) . In order to confirm the capability of myoblasts to form multinucleated myotubes, they were incubated in DMEM/F12 medium with the FBS amount reduced to 10% for 14 days and the myotubes were examined under the phase-contrast microscope (Figure 2 ). Nuclei number 2B ). Flow cytometry results of isolated human skeletal muscle stem cells revealed that they expressed the characteristic surface markers of mesenchymal stem cells -CD44 (95.30% positive), CD90 (96.83% positive), and CD105 (85.58% positive) -and they were negative for hematopoietic cell surface markers CD45 (1.27% positive) and CD34 (0.78% positive) (Figure 3 ).
Neuron-like cell differentiation and characterization
Neuron-like cell differentiation was determined by confocal microscopy after staining the cells for nestin (an early neuronal marker), beta-tubulin3 (a neuronal marker), and GFAP (an astrocyte marker). Neurons and astrocytes can be distinguished with this staining; the cells subjected to neuronal differentiation were found negative for GFAP (Figure 4A ), while they stained positive for betatubulin3 and nestin ( Figure 4B ). Nestin is an intermediate filament protein and neural stem/progenitor cell marker. It was shown to be required for the survival and self-renewal of neural stem cells (Namiki et al., 2012) . During neuroand gliogenesis, nestin is replaced by cell type-specific intermediate filaments such as neurofilaments and GFAP (Michalczyk and Ziman, 2005) .
3.3.
Characterization of HUVECs by immunocytochemistry Phase-contrast micrographs of HUVECs at day 4 of primary culture were obtained and HUVECs at passage 2 were immunostained for endothelial cell surface marker CD31 ( Figure 5 ). HUVECs had the characteristic cobblestone morphology and stained positive for CD31.
Coculture of hSkMSCs and HUVECs
HUVECs and hSkMSCs were incubated in an incubator for 10 days, which is the minimum time required to obtain a capillary network formation in optimized media. After fixation, they were immunostained for the myogenic marker desmin and the endothelial marker CD31.
In DMEM/F12 media supplemented with 5%, 10%, and 20% FBS, the HUVECs did not survive (Figure 6 ). Whenever EGM-2 medium was combined with DMEM/ F12, HUVECs survived and proliferated (Figures 7) .
Although the capillary network formation was more robust in the DMEM/F12 (5% FBS) : EGM-2 (2% FBS) (1:1) mixture ( Figures 7A and 7B) , the myoblasts formed aggregates just beneath the capillary network center and no myotube formation could be detected. The best multinucleated myotube and capillary network formation in the coculture of hSkMSCs and HUVECs was obtained in the DMEM/F12 (10% FBS) : EGM-2 (2% FBS) (1:1) mixture ( Figures 7C and 7D ). On the other hand, when the media mixture with the highest FBS concentration was used (DMEM/F12 (20% FBS) : EGM-2 (2% FBS) (1:1) mixture) ( Figures 7E and 7F) , the capillaries were found to be more stunted and myotube formation could not take place.
In vitro human skeletal muscle model: coculture of myotubes, neuron-like cells, and the capillary network
In order to have the three cell types in the coculture in their differentiated functional state, i.e. myotubes formed by satellite cells, capillaries formed by endothelial cells, and neuron-like cells from hSkMSCs, separate precultures were performed before the final combination step. Coculture of hSkMSCs and HUVECs for 13 days in the DMEM/F12 (10% FBS) : EGM-2 (2% FBS) (1:1) mixture resulted in formation of myotubes and a capillary network. The neuron-like cells were obtained by differentiating the hSkMSCs in a separate culture and were finally transferred on top of the cocultured myotubes and capillaries. Confocal micrographs showed that the neuron-like cells were in association with the myotubes in the coculture of three different cells incubated together for 24 h (Figure 8) .
The Z-stack projection of myotubes and the capillary network maintained in the three-cell coculture is depicted in Figure 9 , which reveals that myotubes were distributed near the bottom and middle sections while the capillary network resided on top of them. 
Discussion
This study aimed to develop a novel human in vitro skeletal muscle model by coculture of human neuron-like cells and myotubes obtained from human skeletal muscle-derived stem cells and a capillary network obtained from human umbilical vein endothelial cells.
The muscle stem cells used in this study were isolated by whole tissue digestion. The preplating method (QuPetersen et al., 2002) was adapted to leave the fast-adhering fibroblasts in the preplate and the experiments were performed with the enriched muscle stem cells. The muscle stem cells, cultured in a medium of high FBS percentage to prevent myoblast maturation, were characterized by flow cytometry for their cell surface markers. Passage 2 cells were determined to be positive for the mesenchymal stem cell markers CD44, CD90, and CD105 and negative for the hematopoietic lineage markers CD34 and CD45. Chirieleison et al. (2012) used the preplate approach to determine the phenotypic characteristics of the human skeletal muscle stem cells that attached differentially to the surface in a time-dependent manner. The skeletal muscle cells used by this group adhered to the tissue culture plate surface between the first 30 and 60 min (PP2) and expressed the same surface markers as the cells used in our study.
Human skeletal muscle contains not only the satellite cells that mature in vitro into myoblasts and fuse with each other to form the myotubes, but also a population of multipotent stem cells that are able to differentiate into osteoblasts, adipocytes, and neurons. Recently, Tamaki et al. (2015) were able to show that CD34-/CD45-/CD29+ cells from human skeletal muscle actively contributed to muscle fiber regeneration in vivo, while CD34+/CD45-cells vigorously engrafted into the interstitium associated with differentiation into Schwann cells and perineural/ endoneural cells together with vascular endothelial cells and pericytes. At least two groups reported differentiation of human skeletal muscle-derived stem cells into neurons in vitro: Alessandri et al. (2004) isolated the skeletal muscle stem cells in a serum-free medium and showed their capability to differentiate into both neurons and astrocytes. Schultz and Lucas (2006) showed the potential of skeletal muscle stem cells to differentiate more into neurons and less into astrocytes when cultured in a neurococktail. A commercially available neuronal differentiation medium was used in our study and the resulting neuron-like cells were found positive for neuronal markers nestin and betatubulin3 and negative for the astrocyte marker GFAP.
In recent years there has been an attempt to generate vascularized muscle flaps through coculture of myoblasts with HUVECs in order to get a better in vivo integration and help the survival of the cells within the thick 3D transplant. HUVECs require a growth factor cocktail to survive and proliferate in vitro. It is known that FBS contains growth factors and mesenchymal stem cells also secrete some growth factors like VEGF that may help HUVEC survival. In a study by Nagamori et al. (2013) , HUVEC migration was studied through the human skeletal muscle myoblast sheets and the capillary network formation was observed within the myoblast sheets. This was attributed to the local feeding of cytokines like VEGF, FGF, and HGF from the myoblasts. However, outside the sheets, HUVECs did not grow in DMEM containing 10% FBS. On the contrary to our expectations, neither an increase in FBS concentration in the DMEM/F12 medium nor the skeletal muscle mesenchymal stem cell support could help HUVEC survival and capillary network formation in the absence of the endothelial cell growth medium. FBS concentration is critical for myotube formation and should be considered in a coculture; FBS promotes myoblast proliferation instead of myoblast fusion when used at a concentration of 20%. Therefore, neither myotubes nor a capillary network could be obtained in the coculture of HUVECs with myoblasts at that concentration in a DMEM/F12 medium.
A 1:1 volumetric combination of DMEM/F12 and EGM-2 helped HUVEC survival and capillary network formation in culture. A final concentration of 3.5% FBS (in the D5:E2 medium), on the other hand, caused myoblast aggregate formation. The best media combination for both capillary network and myotube formation was found as DMEM/F12:EGM-2 with a final FBS concentration of 6%. Increase of FBS concentration to 11% did not cause any improvement and was even found to be worse. When the immortalized mouse myoblast cell line C2C12 was used in such a coculture, fibroblasts were also needed to induce a more physiological capillary network formation by the HUVECs (Levenberg et al., 2005; Shandalov et al., 2014) . On the other hand, when primary human myoblasts were used in coculture with HUVECs, capillary network formation was obtained (Gholobova et al., 2015) without a need for fibroblasts. This outcome can be attributed to the presence of mesenchymal stem cells, or pericytes, among the primary human skeletal muscle-derived cells. Coculture of primary human myoblasts with HUVECs in our study resulted in capillary network formation within 10 days, and as mentioned above it was dependent on the percentage of FBS used in the culture.
To have a better human skeletal muscle model that closely mimics the native tissue's structure and function, there is a need to incorporate motor neurons into the vascularized structure, so that neuromuscular synapses are formed. Neuron-like cells derived from primary human skeletal muscle stem cells were seeded on the vascularized myotubes in our study to obtain neuromuscular junctions in the coculture. Selection and optimization of the culture medium becomes a crucial challenge when the coculture of three different cells is needed in vitro, since every cell type has its own requirements of growth factors and/or hormones. Since each cell type utilizes a medium of different composition, when it comes time to coculture them all together in the same compartment it is essential to determine how these different media or their combinations affect cell morphology and culture consistency. Considering our experience with HUVEC and human skeletal muscle stem cell coculture and the literature on human endothelial cell line and human neural stem cell line coculture (Chou et al., 2014) , it is possible to say that a 50:50 mixture of two specific media supports the cell morphology well in a two-cell coculture. Regarding the coculture of motoneurons with functional myotubes, Guo et al. (2011) showed that an in vitro functional human neuromuscular junction can be established by coculture of motoneurons derived from human fetal spinal cord stem cells and myotubes derived from human skeletal muscle stem cells in a defined serum-free system, which consisted of sequential use of several different media: coculture media rich in neurotrophic factors for 4 days followed by NBActiv 4 medium thereafter. At the end of 24 h of culture of our human skeletal muscle model in the commercial neuronal differentiation medium, the neuron-like cells were found to be alive and in association with the myotubes, and the capillary network was also maintained. Our preliminary results with neuron-like cell and myotube coculture suggest that the neuronal differentiation medium cannot support the intact morphology of myotubes in the coculture beyond 48 h, and it also does not support endothelial cell survival. As was done in the study by Guo et al. (2011) , our three-cell coculture may need a replacement or combination of neuronal differentiation medium with a medium like NBActiv 4 after 24 h of initiation culture. NBActiv 4 medium did not harm endothelial cells in their monoculture carried out for 4 days, but if the capillary network in the three-cell coculture is affected, addition of EGM-2 to the coculture may be considered, too.
To our knowledge, our group has reported for the first time a human skeletal muscle model containing advanced capillary networks, neurons, and myotubes in association with each other, by coculturing HUVECs, myoblasts, and human muscle stem cell-derived neuron-like cells. Takahashi et al. (2015) reported in their very recent study that a capillary network and human induced pluripotent stem cell-derived neurons were associated with human myoblast sheets when sandwiched in between, but myotube and neuromuscular junction formation between the neurons and myotubes was not indicated in this engineered muscle tissue.
In conclusion, in this study, a complex in vitro human skeletal muscle model containing capillary networks and interacting myotubes and neuron-like cells was developed. This skeletal muscle model was characterized by confocal microscopy. The best multinucleated myotube and capillary network formation in the coculture of hSkMSCs and HUVECs was obtained in the DMEM/F12 (10% FBS) : EGM-2 (2% FBS) (1:1 v/v) mixture. Coculture of the myotubes, capillary network, and neuron-like cells was successful for 24 h in the neural differentiation medium. Further detailed analyses such as the determination of the presence and functionality of the neuromuscular junctions in this model and extension of coculture time beyond 24 h are in progress. Our model has the potential to be used in the design of in vitro accurate physiological models of skeletal muscle tissue for various applications like drug testing and toxicology studies. We obtained the composite of muscle fibers, nerves, and capillaries in vitro that would serve as the best muscle tissue substitute for both functional treatment and coverage of a skeletal muscle defect. This model will be useful in ensuring functional muscle regeneration and may eliminate the need for any kind of muscle transfer in future.
